Clinical Trials in Nagoya, Aiti

Find clinical trials in Nagoya, Aiti. Discover local research opportunities and treatment options in your area.

5 Active Trials Found in Nagoya

Showing 5 trials on this page

Page 1 of 1

A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom State

NCT ID: NCT06245408

This clinical trial is studying a new treatment called dazodalibep for patients with Sjögren's Syndrome (SS), specifically those who experience moderate to severe symptoms. The main goal is to see ...

Recruiting

Phase: PHASE3 Conditions: Sjögren's Syndrome (SS)

A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.

NCT ID: NCT05967689

This clinical trial is studying a new drug called zipalertinib for patients with advanced non-small cell lung cancer (NSCLC) that has specific mutations in the epidermal growth factor receptor (EGF...

Recruiting

Phase: PHASE2 Conditions: Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations

A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previously Treated With Other Cancer Therapies

NCT ID: NCT03888105

This clinical trial is studying a new treatment called odronextamab for adults with B-cell non-Hodgkin lymphoma (B-NHL) who have already tried other cancer therapies. The main goal is to see how ef...

Recruiting

Phase: PHASE2 Conditions: B-cell Non-Hodgkin Lymphoma (B-NHL)

Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration

NCT ID: NCT06116890

This clinical trial is studying a new eye drop medication called KHK4951 to see how effective and safe it is for people with neovascular age-related macular degeneration (nAMD). This condition can ...

Recruiting

Phase: PHASE2 Conditions: Neovascular Age-Related Macular Degeneration (nAMD)

A Study to Evaluate How Safe Pozelimab + Cemdisiran Combination Therapy is and How Well it Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have Not Recently Received or Have Not Received Complement Inhibitor Treatment

NCT ID: NCT05133531

This clinical trial is studying a new combination treatment using two experimental drugs called pozelimab and cemdisiran for adults with a condition known as paroxysmal nocturnal hemoglobinuria (PN...

Recruiting

Phase: PHASE3 Conditions: Paroxysmal Nocturnal Hemoglobinuria

Search All Trials Browse All Locations